University of Calgary-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2019

  1. A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

    Cancer Cell, Vol. 36, Núm. 1, pp. 51-67.e7

2017

  1. Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6

2016

  1. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    The Lancet Oncology, Vol. 17, Núm. 4, pp. 484-495

  2. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477